[Federal Register Volume 84, Number 231 (Monday, December 2, 2019)]
[Notices]
[Pages 65990-65991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-2: SBIR Contract Review.
Date: January 15-16, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W102, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Shakeel Ahmad, Ph.D., Chief Research Technology
and Contract Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850, 240-276-6442, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Program Project (P01) Review IV.
Date: January 16-17, 2020.
Time: 7:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Clifford W Schweinfest, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W108, Bethesda, MD 20892-8329, 240-276-6343,
[email protected].
[[Page 65991]]
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational R21 and Omnibus R03.
Date: January 30-31, 2020.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, MD 20850, 240-276-7286, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-4: Cloud-Based Software for the Cancer Research Data
Common.
Date: February 6, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W246, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850, (240) 276-5460,
[email protected].
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee F--Institutional Training and Education.
Date: February 24-25, 2020.
Time: 6:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Bethesda, MD 20892-9750, 240-276-6368,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Innovative Molecular and Cellular Analysis Technologies.
Date: March 4-5, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center.
Montgomery County Conference Center Facility. 5701 Marinelli Road.
North Bethesda, MD 20852.
Contact Person: Jun Fang, Ph.D., Scientific Review Officer,
Research Technology & Contract Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W246, Rockville, MD 20850, (240) 276-5460,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Participant Engagement and Cancer Genome Sequencing Centers.
Date: March 17-18, 2020.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D., Chief, Research Technology
and Contract Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W102, Rockville, MD 20850, 240-276-6442, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-5: NCI Clinical and Translational R21 and Omnibus R03
Review Meeting.
Date: March 26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center,
Montgomery County Conference Center Facility, 5701 Marinelli Road,
North Bethesda, MD 20852.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, 7W234, Bethesda, MD 20892-9750, 240-276-6368,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: November 25, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-25984 Filed 11-29-19; 8:45 am]
BILLING CODE 4140-01-P